Clinical Trials Directory

Trials / Completed

CompletedNCT00347802

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
Sponsor
Innovative Medical · Industry
Sex
All
Age
18 Years
Healthy volunteers

Summary

To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.

Conditions

Interventions

TypeNameDescription
DRUGBimatoprost 0.03%, Travoprost 0.004%

Timeline

First posted
2006-07-04
Last updated
2007-06-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00347802. Inclusion in this directory is not an endorsement.